Healthcare
Ohio’s Mission: Embrace Innovation, Improve Care For All
Ohio’s healthcare industry has commanded worldwide attention for the innovative treatments developed in fields including heart disease, cancer and pediatrics. Researchers, care providers, entrepreneurs, investors, and health system executives have built momentum that is driving a collective mission: to trigger remarkable breakthroughs, treat hundreds of diseases and improve the quality of life of patients worldwide.
Succeed in Ohio
or call 614-224-6446
Found It Here | Amgen
Innovations in gene therapy at Nationwide Children’s Hospital in Columbus, cardiac care at the Cleveland Clinic and pediatric care at Cincinnati Children’s Hospital are contributing to a sector that is attracting world-class researchers, entrepreneurs, and investors.
Ohio’s Healthcare Industry:
- Consists of more than 4,100 bioscience companies.
- Features a growing talent pool of about 80,000 bioscience employees, excluding healthcare providers.
- Is attracting a growing number of bioscience students from Ohio schools, with more than 11,500 graduates in 2018, a 77% increase from 2006.
- Attracted $561 million in capital investments (second in the Midwest) in 2018, according to the BioEnterprise Midwest Capital report.
- Led all Midwest states with 121 biomedical companies receiving investments in 2018. Ohio’s total was 28% of all Midwest companies.
- Includes 13 nationally ranked hospitals, according to U.S. News 2020-2021 Hospitals Ranking. Among the top-ranked systems are:
- Cleveland Clinic, #2 General Hospital
- Cincinnati Children’s, #4 Children’s Hospital
- Nationwide Children’s, #8 Children’s Hospital
Ohio’s Gene Therapy Ecosystem
Ohio has developed an environment that drives cutting-edge gene therapy research and commercialization. That ecosystem, anchored by Nationwide Children’s Hospital and The Ohio State University, attracts global attention and investment.
